DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Medi Assist Healthcare Services Limited — Analyst/Investor Meet Para A-XBRL

NSE 2 hrs ago·27 Oct 2026, 3:03 pm

Medi Assist Health SER L

Medi Assist Healthcare Services Limited has informed stock exchanges about an upcoming meeting with analysts and institutional investors. This is a routine corporate communication where the company management is expected to discuss its business performance, future strategies, and operational outlook with the investment community.

For investors, such meetings often provide valuable insights into the company's direction and management's confidence in its growth trajectory. It serves as a platform to clarify queries and gauge market sentiment regarding the firm's current standing in the healthcare insurance and technology sector.

Investors should watch for any specific guidance provided by the management regarding revenue growth, profitability, or new business initiatives during the discussion. Keeping an eye on the company's official disclosures following the event will help in understanding the broader implications for the stock.